Interferon-gamma alters expression of endothelial cell-surface glycosphingolipids.
Our previous work on human endothelial cell (EC) glycosphingolipids (GSLs) demonstrated that these cells contain a large diversity of GSLs, predominantly with lacto core structures. In order to evaluate the role of GSLs as EC antigens and receptors, we investigated their cell-surface expression on confluent EC monolayers and ECs activated by interferon-gamma (IFN-gamma) and interleukin-1 (IL-1). IFN-gamma activation of endothelial cells resulted in a small change in GSL composition, but greatly increased surface expression of gangliosides and decreased surface expression of neutral GSLs. In particular, surface expression of the major neutral GSL, globoside, decreased three- to fourfold as measured both by galactose oxidase labeling and by binding of the anti-globoside monoclonal antibody 9G7. IFN-gamma did not significantly alter the total cell content of globoside, as measured by metabolic labeling, but rather altered the ratio of accessible cell surface to intracellular globoside. Two mechanisms appear to contribute to the decreased cell-surface globoside expression. IFN-gamma treatment increased the relative proportion of intracellular globoside which is associated with the cell cytoskeleton. IFN-gamma treatment also caused more of the cell-surface globoside to be inaccessible to antibody, and both neuraminidase and trypsin treatment of the cells increased globoside accessibility. IL-1 treatment increased total cell GSL content, but did not alter GSL composition or cell-surface binding by six anti-carbohydrate antibodies. The specific modulation of cell-surface GSLs by IFN-gamma suggests that GSLs may play a role in the altered adhesive and receptor activities of IFN-gamma-activated ECs.
Gillard
B K
BK
Department of Medicine, Baylor College of Medicine, Houston, Texas 77030.
Jones
M A
MA
Turner
A A
AA
Lewis
D E
DE
Marcus
D M
DM
D000906:Antibodies / Q000276:immunology; D002462:Cell Membrane / Q000187:drug effects / Q000378:metabolism / Q000648:ultrastructure; D004727:Endothelium / Q000187:drug effects / Q000378:metabolism* / Q000648:ultrastructure; D005434:Flow Cytometry; D005915:Globosides / Q000096:biosynthesis; D006028:Glycosphingolipids / Q000096:biosynthesis* / Q000276:immunology; D006801:Humans; D007371:Interferon-gamma / Q000494:pharmacology*; D007375:Interleukin-1 / Q000494:pharmacology*; D008856:Microscopy, Fluorescence
D000906:Antibodies; D005915:Globosides; D006028:Glycosphingolipids; D007375:Interleukin-1; D007371:Interferon-gamma